Over the past six months, Merck’s stock price fell to $80.05. Shareholders have lost 6.6% of their capital, which is ...

Pfizer (NYSE:PFE) and Astellas Pharma (OTCPK:ALPMF) announced on Tuesday that their jointly developed antibody-drug conjugate ...

MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected ...

对于2025全年，默沙东集团现预计调整后每股收益在8.87美元至8.97美元之间，缩小了此前8.82美元至8.97美元的预测范围。更新后的展望与分析师共识预期的8.87美元相符。

IO Biotech (IOBT) stock rallies as cancer vaccine, Cylembio, with Merck's (MRK) Keytruda outperforms in a late-stage trial ...

Merck & Co., Inc. (NYSE:MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the ...

Investing.com - Cantor Fitzgerald在默沙东集团 (Merck) (NYSE: MRK )发布第二季度财报后，重申了对该公司的"中性"评级和83.00美元的目标价。根据 InvestingPro 数据，这家制药巨头目前的市盈率为12.8倍，近期有8位分析师下调了其盈利预期。

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, ...

We recently published 13 Stocks That Jim Cramer Recently Talked About. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim ...

Merck (MRK) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.01 per share.

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug ...